| Amgen Switzerland AG - Vectibix 200 mg, Konzentrat zur Herstellung einer Infusionslösung |
| 57872 | | 02 | | Vectibix 200 mg | | Konzentrat zur Herstellung einer Infusionslösung | | L01XC08 | | Panitumumab | | 14.10.2008 | | |
|
| Composition |
| panitumumabum 200 mg, natrii acetas trihydricus, natrii chloridum, aqua ad iniectabilia q.s. ad solutionem pro 10 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Panitumumabum | 200mg / 10ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
